BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 22448965)

  • 1. Searching for new chemotherapies for tropical diseases: ruthenium-clotrimazole complexes display high in vitro activity against Leishmania major and Trypanosoma cruzi and low toxicity toward normal mammalian cells.
    Martínez A; Carreon T; Iniguez E; Anzellotti A; Sánchez A; Tyan M; Sattler A; Herrera L; Maldonado RA; Sánchez-Delgado RA
    J Med Chem; 2012 Apr; 55(8):3867-77. PubMed ID: 22448965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metal-drug synergy: new ruthenium(II) complexes of ketoconazole are highly active against Leishmania major and Trypanosoma cruzi and nontoxic to human or murine normal cells.
    Iniguez E; Sánchez A; Vasquez MA; Martínez A; Olivas J; Sattler A; Sánchez-Delgado RA; Maldonado RA
    J Biol Inorg Chem; 2013 Oct; 18(7):779-90. PubMed ID: 23881220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward a novel metal-based chemotherapy against tropical diseases. 6. Synthesis and characterization of new copper(II) and gold(I) clotrimazole and ketoconazole complexes and evaluation of their activity against Trypanosoma cruzi.
    Navarro M; Cisneros-Fajardo EJ; Lehmann T; Sánchez-Delgado RA; Atencio R; Silva P; Lira R; Urbina JA
    Inorg Chem; 2001 Dec; 40(27):6879-84. PubMed ID: 11754267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antileishmanial activity of ruthenium(II)tetraammine nitrosyl complexes.
    Pereira JC; Carregaro V; Costa DL; da Silva JS; Cunha FQ; Franco DW
    Eur J Med Chem; 2010 Sep; 45(9):4180-7. PubMed ID: 20598778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel ruthenium(II) cyclopentadienyl thiosemicarbazone compounds with antiproliferative activity on pathogenic trypanosomatid parasites.
    Fernández M; Arce ER; Sarniguet C; Morais TS; Tomaz AI; Azar CO; Figueroa R; Diego Maya J; Medeiros A; Comini M; Helena Garcia M; Otero L; Gambino D
    J Inorg Biochem; 2015 Dec; 153():306-314. PubMed ID: 26275470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuning the reactivity of osmium(II) and ruthenium(II) arene complexes under physiological conditions.
    Peacock AF; Habtemariam A; Fernández R; Walland V; Fabbiani FP; Parsons S; Aird RE; Jodrell DI; Sadler PJ
    J Am Chem Soc; 2006 Feb; 128(5):1739-48. PubMed ID: 16448150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ruthenium(II/III)-based compounds with encouraging antiproliferative activity against non-small-cell lung cancer.
    Nagy EM; Pettenuzzo A; Boscutti G; Marchiò L; Dalla Via L; Fregona D
    Chemistry; 2012 Nov; 18(45):14464-72. PubMed ID: 23012112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spectroscopic Study of the Interactions of Ruthenium-Ketoconazole Complexes of Known Antiparasitic Activity with Human Serum Albumin and Apotransferrin.
    Estrada JG; Sánchez-Delgado RA
    J Mex Chem Soc; 2013; 57(3):169-174. PubMed ID: 24391686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies for overcoming tropical disease by ruthenium complexes with purine analog: Application against Leishmania spp. and Trypanosoma cruzi.
    Fandzloch M; Arriaga JMM; Sánchez-Moreno M; Wojtczak A; Jezierska J; Sitkowski J; Wiśniewska J; Salas JM; Łakomska I
    J Inorg Biochem; 2017 Nov; 176():144-155. PubMed ID: 28910663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ruthenium(II) complexes of 1,3-thiazolidine-2-thione: Cytotoxicity against tumor cells and anti-Trypanosoma cruzi activity enhanced upon combination with benznidazole.
    Corrêa RS; da Silva MM; Graminha AE; Meira CS; Santos JA; Moreira DR; Soares MB; Von Poelhsitz G; Castellano EE; Bloch C; Cominetti MR; Batista AA
    J Inorg Biochem; 2016 Mar; 156():153-63. PubMed ID: 26795676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The contrasting chemistry and cancer cell cytotoxicity of bipyridine and bipyridinediol ruthenium(II) arene complexes.
    Bugarcic T; Habtemariam A; Stepankova J; Heringova P; Kasparkova J; Deeth RJ; Johnstone RD; Prescimone A; Parkin A; Parsons S; Brabec V; Sadler PJ
    Inorg Chem; 2008 Dec; 47(24):11470-86. PubMed ID: 19007206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bipyrimidine ruthenium(II) arene complexes: structure, reactivity and cytotoxicity.
    Betanzos-Lara S; Novakova O; Deeth RJ; Pizarro AM; Clarkson GJ; Liskova B; Brabec V; Sadler PJ; Habtemariam A
    J Biol Inorg Chem; 2012 Oct; 17(7):1033-51. PubMed ID: 22791215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chlorido-, aqua-, 9-ethylguanine- and 9-ethyladenine-adducts of cytotoxic ruthenium arene complexes containing O,O-chelating ligands.
    Melchart M; Habtemariam A; Parsons S; Sadler PJ
    J Inorg Biochem; 2007 Nov; 101(11-12):1903-12. PubMed ID: 17582501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ruthenium-Clotrimazole complex has significant efficacy in the murine model of cutaneous leishmaniasis.
    Iniguez E; Varela-Ramirez A; Martínez A; Torres CL; Sánchez-Delgado RA; Maldonado RA
    Acta Trop; 2016 Dec; 164():402-410. PubMed ID: 27693373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Half-sandwich ruthenium–arene complexes with thiosemicarbazones: synthesis and biological evaluation of [(η⁶-p-cymene)Ru(piperonal thiosemicarbazones)Cl]Cl complexes.
    Beckford F; Dourth D; Shaloski M; Didion J; Thessing J; Woods J; Crowell V; Gerasimchuk N; Gonzalez-Sarrías A; Seeram NP
    J Inorg Biochem; 2011 Aug; 105(8):1019-29. PubMed ID: 21666776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organometallic ruthenium(II) diamine anticancer complexes: arene-nucleobase stacking and stereospecific hydrogen-bonding in guanine adducts.
    Chen H; Parkinson JA; Parsons S; Coxall RA; Gould RO; Sadler PJ
    J Am Chem Soc; 2002 Mar; 124(12):3064-82. PubMed ID: 11902898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of cancer cell growth by ruthenium(II) arene complexes.
    Morris RE; Aird RE; Murdoch Pdel S; Chen H; Cummings J; Hughes ND; Parsons S; Parkin A; Boyd G; Jodrell DI; Sadler PJ
    J Med Chem; 2001 Oct; 44(22):3616-21. PubMed ID: 11606126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coordination of nitro-thiosemicarbazones to ruthenium(II) as a strategy for anti-trypanosomal activity improvement.
    Rodrigues C; Batista AA; Ellena J; Castellano EE; Benítez D; Cerecetto H; González M; Teixeira LR; Beraldo H
    Eur J Med Chem; 2010 Jul; 45(7):2847-53. PubMed ID: 20363536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multifunctional Organometallic Compounds Active against Infective Trypanosomes: Ru(II) Ferrocenyl Derivatives with Two Different Bioactive Ligands.
    Rivas F; Del Mármol C; Scalese G; Pérez Díaz L; Machado I; Blacque O; Salazar F; Coitiño EL; Benítez D; Medeiros A; Comini M; Gambino D
    Inorg Chem; 2024 Jun; 63(25):11667-11687. PubMed ID: 38860314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coordinatively diverse ortho-phosphinoaniline complexes of ruthenium and isolation of a putative intermediate in ketone transfer hydrogenation catalysis.
    Hounjet LJ; Bierenstiel M; Ferguson MJ; McDonald R; Cowie M
    Inorg Chem; 2010 May; 49(9):4288-300. PubMed ID: 20364836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.